Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- Check3 days agoChange DetectedThe site revision has been updated from v3.6.3 to v3.6.4, indicating a new deployment. The update does not modify the study content or user-facing functions on this page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedVersion revision on the page was updated from v3.6.2 to v3.6.3, representing a minor update to the site's page template or backend. No study content or data changes are implied by this update.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.6.2 appears on the page, replacing the previous v3.6.0. This indicates a minor platform update rather than changes to the study data.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded posted results for the AFPc332T study (NCT03132792), including safety endpoints (DLTs, TEAEs, SAEs), efficacy endpoints (ORR, DoR, PFS, OS), and enrollment details (39 participants). Also added access to official documents (Study Protocol and SAP) and updated results timing information (results posted/submitted dates).SummaryDifference3%

- Check46 days agoChange DetectedDifference0.4%

- Check53 days agoChange DetectedThe page's revision label has been updated from v3.5.4 to v3.5.5, signaling a minor update to the page's underlying version tracking.SummaryDifference0.0%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.